HuGE Literature Finder
Records
1
-
23
| Comprehensive Analysis of Prognosis and Immune Landscapes Based on Lipid-Metabolism- and Ferroptosis-Associated Signature in Uterine Corpus Endometrial Carcinoma. Diagnostics (Basel, Switzerland) 2023 3 13 (5): . Yang Pusheng, Lu Jiawei, Zhang Panpan, Zhang S |
| Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer. Cytokine 2022 Sep 160 156024. Padala Chiranjeevi, Puranam Kaushik, Shyamala Nivas, Kupsal Keerthi, Kummari Ramanjaneyulu, Galimudi Rajesh Kumar, Gundapaneni Kishore Kumar, Tupurani Mohini Aiyengar, Suryadevera Aparna, Chinta Sanjeeva Kumari, Manavathi Bramanandam, Hanumanth Surekha Ra |
| Identification of tumour antigens and immune subtypes in the development of an anti-cancer vaccine for endometrial carcinoma. Scandinavian journal of immunology 2022 12 97 (3): e13250. Feng Jianyang, He Ho |
| Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast. Communications biology 2021 4 4 (1): 438. Nagasawa Satoi, Kuze Yuta, Maeda Ichiro, Kojima Yasuyuki, Motoyoshi Ai, Onishi Tatsuya, Iwatani Tsuguo, Yokoe Takamichi, Koike Junki, Chosokabe Motohiro, Kubota Manabu, Seino Hibiki, Suzuki Ayako, Seki Masahide, Tsuchihara Katsuya, Inoue Eisuke, Tsugawa Koichiro, Ohta Tomohiko, Suzuki Yuta |
| Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma in situ: Results from the UK/ANZ DCIS Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 3 27 (10): 2861-2867. Thorat Mangesh A, Levey Pauline M, Jones J Louise, Pinder Sarah E, Bundred Nigel J, Fentiman Ian S, Cuzick Ja |
| DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas. Chinese medical journal 2019 1 132 (2): 161-170. He Dan, Wang Xiao, Zhang Yan, Zhao Jian, Han Rui, Dong Yi |
| Clinicopathological features of breast cancer in Japanese female patients with Lynch syndrome. Breast cancer (Tokyo, Japan) 2018 11 26 (3): 359-364. Kanaya Nobuhiko, Tanakaya Kohji, Yamasaki Rie, Arata Takashi, Shigeyasu Kunitoshi, Aoki Hideki, Morito Toshiaki, Sanaii Hiromi, Akagi Kiwamu, Fujiwara Toshiyos |
| Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing. Genes, chromosomes & cancer 2018 02 57 (2): 51-60. Shibuya Yusuke, Tokunaga Hideki, Saito Sakae, Shimokawa Kazurou, Katsuoka Fumiki, Bin Li, Kojima Kaname, Nagasaki Masao, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
| In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+ and HER2 2+/Her2 amplified cases. Virchows Archiv : an international journal of pathology 2016 Apr . Giuliani Silvia, Ciniselli Chiara Maura, Leonardi Elena, Polla Enzo, Decarli Nicola, Luchini Claudio, Cantaloni Chiara, Gasperetti Fabio, Cazzolli Daniela, Berlanda Gabriella, Bernardi Daniela, Pellegrini Marco, Triolo Renza, Ferro Antonella, Verderio Paolo, Barbareschi Matt |
| Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis. BMC cancer 2016 07 16 375. Gargiulo Piera, Pensabene Matilde, Milano Monica, Arpino Grazia, Giuliano Mario, Forestieri Valeria, Condello Caterina, Lauria Rossella, De Placido Sabi |
| HER2 mutation status in Japanese HER2-positive breast cancer patients. Breast cancer (Tokyo, Japan) 2015 Dec . Endo Yumi, Dong Yu, Kondo Naoto, Yoshimoto Nobuyasu, Asano Tomoko, Hato Yukari, Nishimoto Mayumi, Kato Hiroyuki, Takahashi Satoru, Nakanishi Ryoichi, Toyama Tatsu |
| Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy. Journal of experimental & clinical cancer research : CR 2015 34 2. Tecza Karolina, Pamula-Pilat Jolanta, Kolosza Zofia, Radlak Natalia, Grzybowska E |
| [Endometrial cancer in young women--clinical and molecular aspects]. Ginekologia polska 2014 12 85 (10): 754-9. Lapi?ska-Szumczyk Sylwia, Supernat Anna, ?aczek Anna J, Majewska Hanna, Gulczy?ski Jacek, Sawicki Sambor, Biernat Wojciech, Wydra Dariu |
| Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features. Breast cancer research : BCR 2014 10 16 (5): 423. Pang Jia-Min B, Deb Siddhartha, Takano Elena A, Byrne David J, Jene Nicholas, Boulghourjian Alice, Holliday Anne, Millar Ewan, Lee C Soon, O'Toole Sandra A, Dobrovic Alexander, Fox Stephen |
| Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer. Neoplasma 2013 8 60 (6): 635-46. Zmetakova I, Danihel L, Smolkova B, Mego M, Kajabova V, Krivulcik T, Rusnak I, Rychly B, Danis D, Repiska V, Blasko P, Karaba M, Benca J, Pechan J, Fridrichova |
| CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Asian Pacific journal of cancer prevention : APJCP 2012 4 13 (2): 451-7. Ramezani Fatemeh, Salami Siamak, Omrani Mir Davood, Maleki Davo |
| Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PloS one 2012 7 (7): e40162. Srivastava Anshika, Sharma Kiran Lata, Srivastava Neena, Misra Sanjeev, Mittal Balr |
| Association of DNMT1 gene polymorphisms in exons with sporadic infiltrating ductal breast carcinoma among Chinese Han women in the Heilongjiang Province. Clinical breast cancer 2010 Oct 10 (5): 373-7. Xiang Gao, Zhenkun Fu, Shuang Chen, Jie Zhang, Hua Zhang, Wei Jiang, Da Pang, Dianjun |
| Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecologic oncology 2010 11 120 (1): 113-20. Liggett Thomas E, Melnikov Anatoliy, Yi Qilong, Replogle Charles, Hu Wei, Rotmensch Jacob, Kamat Aparna, Sood Anil K, Levenson Vict |
| PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. The Journal of pathology 2006 Feb 208 (3): 350-5. Buttitta Fiamma, Felicioni Lara, Barassi Fabio, Martella Carla, Paolizzi Diego, Fresu Giuseppina, Salvatore Simona, Cuccurullo Franco, Mezzetti Andrea, Campani Daniela, Marchetti Anton |
| CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC cancer 2006 3 6 48. Caldeira José Roberto F, Prando Erika C, Quevedo Francisco C, Neto Francisco A Moraes, Rainho Cláudia A, Rogatto Silvia |
| Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*. Breast cancer research and treatment 2005 9 94 (1): 11-6. Zhang Zhenhuan, Yamashita Hiroko, Toyama Tatsuya, Sugiura Hiroshi, Ando Yoshiaki, Mita Keiko, Hamaguchi Maho, Hara Yasuo, Kobayashi Shunzo, Iwase Hirota |
| Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients. International journal of cancer. Journal international du cancer 2001 Nov 95 (6): 394-7. Tong D, Fabjani G, Heinze G, Obermair A, Leodolter S, Zeillinger |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: